Kan H, Ruan Y, Malik K U
Department of Pharmacology, College of Medicine, University of Tennessee Center for the Health Sciences, Memphis 38163, USA.
Mol Pharmacol. 1996 Nov;50(5):1139-47.
We previously showed that acetylcholine (ACh) stimulates production of prostacyclin, measured as immunoreactive 6-keto-prostaglandin F1 alpha (6-keto-PGF1 alpha), in coronary endothelial cells (CEC) of rabbit heart by increasing influx of extracellular Ca2+ through a receptor-operated Ca2+ channel and by activating a pertussis toxin-insensitive G protein. The purposes of this study were to elucidate the type of phospholipase A2 (PLA2) involved in 6-keto-PGF1 alpha production and the mechanism(s) by which ACh activates PLA2 in cultured CEC. In CEC transiently transfected with cytosolic PLA2 but not secretory PLA2 antisense oligonucleotide, ACh failed to increase 6-keto-PGF1 alpha; this was prevented by cotransfection with cPLA2 sense oligonucleotide. ACh increased production of prostacyclin and increased protein kinase C (PKC) activity. The PKC inhibitor calphostin C attenuated the ACh-induced increase in PKC activity but not 6-keto-PGF1 alpha production. Phorbol-12-myristate-13-acetate and phorbol-12, 13-dibutyrate increased PKC activity but failed to alter 6-keto-PGF1 alpha production. ACh enhanced the activity of cPLA2 and p42 mitogen-activated protein kinase (MAPK) in cell lysate prepared from CEC. ACh also caused phosphorylation of p42 MAPK and cPLA2, which was inhibited by AG126 ([alpha-cyano-(3-hydroxy-4-nitro)cinnamonitrile]), a tyrosine kinase inhibitor known to decrease MAPK activity. In addition, ACh stimulated translocation of cPLA2 from cytosol to nuclear envelope; the translocation of cPLA2 was prevented by removal of extracellular calcium but not by AG126 treatment. Okadaic acid, a protein phosphatase inhibitor, increased cPLA2 activity in cell lysate prepared from CEC but did not alter basal 6-keto-PGF1 alpha production in intact CEC; however, ACh-induced 6-keto-PGF1 alpha was enhanced by okadaic acid. These data suggest that ACh stimulates prostacyclin synthesis by activation of cPLA2 in a PKC-independent mechanism and that both cPLA2 translocation to nuclear envelope and phosphorylation by MAPK are required for ACh-induced 6-keto-PGF1 alpha synthesis in CEC.
我们先前的研究表明,乙酰胆碱(ACh)通过增加细胞外Ca2+经受体操纵的Ca2+通道内流,并激活一种对百日咳毒素不敏感的G蛋白,刺激兔心脏冠状动脉内皮细胞(CEC)中前列环素的生成,以前列环素免疫反应性6-酮-前列腺素F1α(6-酮-PGF1α)来衡量。本研究的目的是阐明参与6-酮-PGF1α生成的磷脂酶A2(PLA2)类型以及ACh在培养的CEC中激活PLA2的机制。在瞬时转染胞质型PLA2而非分泌型PLA2反义寡核苷酸的CEC中,ACh未能增加6-酮-PGF1α;与胞质型PLA2正义寡核苷酸共转染可防止这种情况发生。ACh增加了前列环素的生成并提高了蛋白激酶C(PKC)的活性。PKC抑制剂钙泊三醇减弱了ACh诱导的PKC活性增加,但未减弱6-酮-PGF1α的生成。佛波醇-12-肉豆蔻酸酯-13-乙酸酯和佛波醇-12,13-二丁酸酯增加了PKC活性,但未能改变6-酮-PGF1α的生成。ACh增强了CEC制备的细胞裂解物中胞质型PLA2和p42丝裂原活化蛋白激酶(MAPK)的活性。ACh还导致p42 MAPK和胞质型PLA2的磷酸化,这被AG126([α-氰基-(3-羟基-4-硝基)肉桂腈])抑制,AG126是一种已知可降低MAPK活性的酪氨酸激酶抑制剂。此外,ACh刺激胞质型PLA2从胞质溶胶转位至核膜;去除细胞外钙可防止胞质型PLA2的转位,但AG126处理则不能。冈田酸是一种蛋白磷酸酶抑制剂,它增加了CEC制备的细胞裂解物中胞质型PLA2的活性,但未改变完整CEC中的基础6-酮-PGF1α生成;然而,冈田酸增强了ACh诱导的6-酮-PGF1α生成。这些数据表明,ACh通过以一种不依赖PKC的机制激活胞质型PLA2来刺激前列环素的合成,并且胞质型PLA2转位至核膜以及被MAPK磷酸化对于ACh诱导CEC中6-酮-PGF1α的合成都是必需的。